These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 38408152)
21. Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Pajno GB; Bernardini R; Peroni D; Arasi S; Martelli A; Landi M; Passalacqua G; Muraro A; La Grutta S; Fiocchi A; Indinnimeo L; Caffarelli C; Calamelli E; Comberiati P; Duse M; Ital J Pediatr; 2017 Jan; 43(1):13. PubMed ID: 28257631 [TBL] [Abstract][Full Text] [Related]
22. The Art of Immunotherapy. Nelson HS J Allergy Clin Immunol Pract; 2024 Jan; 12(1):1-10. PubMed ID: 37898175 [TBL] [Abstract][Full Text] [Related]
23. Allergen-specific Immunotherapy for Inhalant Allergens in Children. Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis. Yang J; Lei S Front Immunol; 2023; 14():1274241. PubMed ID: 38162647 [TBL] [Abstract][Full Text] [Related]
25. Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy. Nelson HS Allergy Asthma Proc; 2020 Jan; 41(1):26-37. PubMed ID: 31888780 [No Abstract] [Full Text] [Related]
26. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463 [TBL] [Abstract][Full Text] [Related]
27. Preventive capacity of allergen immunotherapy on the natural history of allergy. Incorvaia C J Prev Med Hyg; 2013 Jun; 54(2):71-4. PubMed ID: 24396984 [TBL] [Abstract][Full Text] [Related]
28. Patient initiation and persistence with allergen immunotherapy. Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759 [TBL] [Abstract][Full Text] [Related]
29. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study. Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918 [TBL] [Abstract][Full Text] [Related]
30. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
31. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
32. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan. Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930 [TBL] [Abstract][Full Text] [Related]
33. Safety of allergen-specific immunotherapy in children. De Filippo M; Votto M; Caminiti L; Panasiti I; Carella F; De Castro G; Landi M; Olcese R; Vernich M; Marseglia GL; Ciprandi G; Barberi S Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):27-30. PubMed ID: 35080302 [TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025 [TBL] [Abstract][Full Text] [Related]
35. Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis. Abdullah B; Pawankar R; Abdul Latiff AH; Woo KCK; Wüstenberg E; Khalid MAF; Xiang YZ; Husain S; Mohammad N; Md Shukri N J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769797 [TBL] [Abstract][Full Text] [Related]
36. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
37. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767 [TBL] [Abstract][Full Text] [Related]
39. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Nolte H; Maloney J Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659 [TBL] [Abstract][Full Text] [Related]
40. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows. Votto M; De Filippo M; Caminiti L; Carella F; de Castro G; Landi M; Olcese R; Vernich M; Marseglia GL; Ciprandi G; Barberi S Pediatr Allergy Immunol; 2021 Jul; 32(5):814-823. PubMed ID: 33503273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]